BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15661094)

  • 1. Shortcomings in pharmacy benefit forecasting--interferon beta products.
    Rich SJ; Meyer C
    J Manag Care Pharm; 2003; 9(4):373; author reply 374. PubMed ID: 14613461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Ren D; Jin J; Xiong S; Xia D; Zhao X; Guo H; Yang X; Yu J; Liang T; Guo L
    Clin Transl Med; 2024 Apr; 14(4):e1669. PubMed ID: 38659057
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland.
    Scotti B; Disanto G; Sacco R; Guigli M; Zecca C; Gobbi C
    PLoS One; 2018; 13(5):e0197415. PubMed ID: 29758075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["The largest snapshot of multiple sclerosis". Interferons compared].
    MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866307
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon beta for treatment of multiple sclerosis.
    Wilson BA
    Medsurg Nurs; 1995 Apr; 4(2):151-3. PubMed ID: 7711824
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferons in multiple sclerosis.
    Kappos L
    Neurol Clin; 2005 Feb; 23(1):189-214, vii-viii. PubMed ID: 15661094
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of interferon beta at the time of initial diagnosis of multiple sclerosis.
    Pender MP
    J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589
    [No Abstract]   [Full Text] [Related]  

  • 8. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?
    Hodgkinson SJ
    J Clin Neurosci; 2001 Jul; 8(4):378-9. PubMed ID: 11437587
    [No Abstract]   [Full Text] [Related]  

  • 9. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against.
    Macdonell R
    J Clin Neurosci; 2001 Jul; 8(4):379-81. PubMed ID: 11437588
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.